Fundraising Fox

Pagari Life Science

Bethalta, US · Founded 2022 · Delaware corporation

BiotechHealthtech

Founders & leadership

SP
Stephen PeipertExecutive
JW
James WickenhauserExecutive
MZ
Marni ZenkewiczExecutive
DF
David FeldkerExecutive
AW
Alan WickenhauserNamed on SEC filing
SP
Stephen PiepertNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$678K disclosed across 4 rounds · 2023–2026

▶$97.5KraisedMay 2026 · 8 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • James WickenhauserExecutive Officer
  • Marni ZenkewiczExecutive Officer
  • David FeldkerExecutive Officer, Director
  • Stephen PeipertExecutive Officer, Director
Offering amount
$300K
Amount sold
$97.5K
First sale
Apr 2026
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$55.5KraisedMay 2025 · 6 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Stephen PeipertExecutive Officer, Director
  • James WickenhauserExecutive Officer
  • Marni ZenkewiczExecutive Officer
  • David FeldkerExecutive Officer, Director
Offering amount
$4M
Amount sold
$55.5K
First sale
May 2025
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$275KraisedApr 2024 · 2 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Marni ZenkewiczExecutive Officer
  • James WickenhauserExecutive Officer
  • David FeldkerExecutive Officer, Director
  • Stephen PeipertDirector
  • Alan WickenhauserDirector
Offering amount
$600K
Amount sold
$275K
First sale
Mar 2024
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$250KraisedOct 2023 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Marni ZenkewiczExecutive Officer
  • David FeldkerDirector
  • Alan WickenhauserDirector
  • Stephen PiepertDirector
  • James WickenhauserExecutive Officer
Offering amount
$450K
Amount sold
$250K
First sale
Oct 2023
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Pagari Life Science raised?
Pagari Life Science has disclosed $678K raised across 4 rounds.
Where is Pagari Life Science headquartered?
Pagari Life Science is headquartered in Bethalta, US.